Skip to main content
< Back
About
About the conference
Latest updates
Organisers & Partners
App
Press room
Programme 19
Full programme
Tracks
Speakers 19
Keynote speakers
All speakers
Side events 19
Venue 19
About the venue
Location
Rooms
Subscribe
Programme evaluation
Sessions
Plenary session
Poster session
Big debate
Structured session
Workshop
Oral presentation session
Short communication session
Poster guided tour
Criminal justice/prisons — Programme evaluation
Infectious diseases — Programme evaluation
Programme evaluation — Clinical tools
Programme evaluation — Vulnerable groups
Thursday, 08 August
14:00
Emerging findings from a longitudinal evaluation
Police training to reduce drug-related harm in Mexico
14:00
14:15
An overview of the 'Parents Under Pressure Program'
Working with complex families with parental substance abuse
14:15
Wednesday, 23 October
10:50
A multi-disciplinary, mixed-methods approach
Development of a core outcome set for treatment of substance use and addictive behaviour disorders
10:50
to
12:20
Futures zone 3 (F3)
Michael Farrell
13:20
Political approaches, tensions and compromises behind a new political consensus
2009-2019 — A crucial decade in international drug policy
13:20
to
14:50
Central square 2 (C2)
Lotta Lampela
Improving delivery of healthcare programmes
13:20
to
14:50
Central square 3 (C3)
Graça Vilar
Modelling the impact of decriminalisation
13:20
to
14:50
Networking zone 1 (N1)
Rosalie Pacula
15:00
Prevention strategies
15:00
to
16:30
Insights zone 2 (I2)
Angelina Brotherhood
Therapeutic horizons I
15:00
to
16:30
Networking zone 1 (N1)
Wouter Vanderplasschen
18:30
Consumption rooms: overcoming implementation challenges
18:30
to
19:30
Insights zone 4 (I4)
Ricardo Fuertes
Treatment in the justice system
18:30
to
19:30
Central square 2 (C2)
Sharon Dawe
Thursday, 24 October
13:20
Injecting, risk and reducing harm
13:20
to
14:50
Networking zone 3 (N3)
Thomas Néfau
Evidence to guide future practice and policy
Enhancing hepatitis C treatment outcomes among people who use drugs
13:20
to
14:50
Insights zone 1 (I1)
Catharina Matheï
Adrian Dunlop
16:50
Methods and measurement of economic cost of substance use
16:50
to
18:20
Central square 3 (C3)
Rosalie Pacula
Friday, 25 October
10:45
Approaches to support the development of an evaluative culture to promote better drug policy for the future
10:45
to
12:15
Networking zone 2 (N2)
Liesbeth Vandam
Presentations
Plenary session
Poster session
Big debate
Structured session
Workshop
Oral presentation session
Short communication session
Poster guided tour
Wednesday, 23 October
11:00
Oral presentation
ICHOM Standard Set development process
11:00
to
11:15
Futures zone 3 (F3)
Nicola Black
11:15
Oral presentation
Preliminary recommendations
11:15
to
11:30
Futures zone 3 (F3)
Sophie Chung
11:30
Panellists
11:30
to
12:00
Futures zone 3 (F3)
Henrietta Bowden-Jones OBE
Marica Ferri
Peter Kelly
Brian Rush
Marta Torrens Melich
Joanne Neale
Nicholas Lintzeris
12:00
Conclusion
12:00
to
12:20
Futures zone 3 (F3)
Michael Farrell
13:30
Oral presentation
A retrospective analysis of a turbulent decade for drug policy; 2009-2019
13:30
to
13:45
Central square 2 (C2)
Danilo Ballotta
Oral presentation
Models for the decriminalisation, depenalisation and diversion of illicit drug possession: an international realist review
13:30
to
13:45
Networking zone 1 (N1)
Caitlin Hughes
Oral presentation
Balancing welfare and market institutional logics. Procurement regulations for social services, such as addiction treatment, in four Nordic welfare countries
13:30
to
13:45
Central square 3 (C3)
Kerstin Stenius
13:45
Oral presentation
To what extent will the drug-crime nexus remain after drug laws liberalisation? An examination of criminal charges among patients in treatment for cannabis use disorders and controls under varied drug policy regimes
13:45
to
14:00
Networking zone 1 (N1)
Anne Line Bretteville-Jensen
Oral presentation
Can liaison and diversion services increase referral to drug and alcohol treatment?
13:45
to
14:00
Central square 3 (C3)
Kate Morley
Oral presentation
Views, positions and objectives of Russia and like-minded countries
13:45
to
14:00
Central square 2 (C2)
Anna Nazarova
14:00
Oral presentation
Views, positions and objectives of Mexico and like-minded countries to tackle the world drug problem
14:00
to
14:15
Central square 2 (C2)
Diego Simancas
Oral presentation
The law enforcement costs of de facto 'criminalising' drug possession: the Italian experience
14:00
to
14:15
Networking zone 1 (N1)
Davide Fortin
Oral presentation
Treatment in therapeutic communities: the experience of Lisbon and Tagus Valley Region
14:00
to
14:15
Central square 3 (C3)
Elizabete Pereira
14:15
Oral presentation
A viewpoint from civil society
14:15
to
14:30
Central square 2 (C2)
Marie Nougier
Oral presentation
Introducing a new cannabis decriminalisation policy: The unintentional effects on cannabis perceptions and use among Israeli youth
14:15
to
14:30
Networking zone 1 (N1)
Yossi Harel-Fisch
Oral presentation
The influence of institutional response on the individual's recovery from drug misuse
14:15
to
14:30
Central square 3 (C3)
Carolina Cunha
14:30
Comment: The role and relevance of multilateralism
14:30
to
14:45
Central square 2 (C2)
Doris Resch
15:10
Oral presentation
A peer-led integrated approach for co-existing mental and addictive disorders: a longitudinal qualitative study of the first UK dual diagnosis anonymous
15:10
to
15:25
Networking zone 1 (N1)
Raffaella Margherita Milani
Oral presentation
Recognising that behaviour is often automatic, contingent on environmental cues and with limited self-regulation: the potentials of environmental prevention
15:10
to
15:25
Insights zone 2 (I2)
Gregor Burkhart
15:25
Oral presentation
m-Health among illicit drug users: effectiveness, differential indication, risks and negative effects and ongoing developments among guided and unguided interventions
15:25
to
15:40
Networking zone 1 (N1)
Michael Schaub
Oral presentation
Invalidating adolescents' pro-cannabis opinions: a new tactic of prevention
15:25
to
15:40
Insights zone 2 (I2)
William Crano
15:40
Oral presentation
Associations of ketamine use with mental health and substance use outcomes at 12 months follow-up in young Europeans
15:40
to
15:55
Networking zone 1 (N1)
Meryem Grabski
Oral presentation
IDART- a national study on targeted injury prevention
15:40
to
15:55
Insights zone 2 (I2)
Benedicte Joergenrund
15:55
Oral presentation
The acceptability of psychedelics as treatment options in psychiatry. Data from GDS2019
15:55
to
16:10
Networking zone 1 (N1)
Adam Winstock
Oral presentation
Results of the EPOPS project: adaptation, implementation and evaluation of a programme empowering parents organisations for alcohol prevention in Spain and Portugal
15:55
to
16:10
Insights zone 2 (I2)
Cátia Magalhães
16:10
Oral presentation
Effectiveness and cost-effectiveness of adjunctive personalised psychosocial intervention in treatment-resistant maintenance opioid agonist therapy: a pragmatic, open-label, randomised controlled trial
16:10
to
16:25
Networking zone 1 (N1)
John Marsden
Oral presentation
Adolescents in need - study of the origin and demands of adolescents and youngsters arriving at West Lisbon CRI indicated prevention locals
16:10
to
16:25
Insights zone 2 (I2)
Isabel Prata Duarte
18:30
Oral presentation
Translating and transferring drug prevention interventions across contexts: Learning from the EPPIC project :‘Exchanging Prevention practices on Polydrug use among youth in Criminal justice systems’ (CJS)
18:30
to
18:45
Central square 2 (C2)
Rachel Herring
Oral presentation
Acceptability and willingness to use a mobile drug consumption room in Lisbon
18:30
to
18:45
Insights zone 4 (I4)
Adriana Curado
18:45
Oral presentation
Peer recovery specialists in the drug treatment court: impact on participant outcomes from a randomised controlled trial
18:45
to
19:00
Central square 2 (C2)
Steven Belenko
Oral presentation
Drug consumption rooms – from a conceptual framework to a basic institutionalised service. The experience of Germany
18:45
to
19:00
Insights zone 4 (I4)
Ingo Michels
19:00
Oral presentation
'My first 48 hours out': continuity of health and psychosocial care for drug users after release from prison in four European countries
19:00
to
19:15
Central square 2 (C2)
Wouter Vanderplasschen
Oral presentation
How to develop a common adherence of all the stakeholders when implementing a drug consumption room?
19:00
to
19:15
Insights zone 4 (I4)
Sanda Samitca
19:15
Oral presentation
Coercion into addiction treatment and subsequent substance use patterns among people who use illicit drugs in Vancouver, Canada
19:15
to
19:30
Central square 2 (C2)
Andreas Pilarinos
Oral presentation
Against political odds: the establishment of a drug consumption room in Belgium.
19:15
to
19:30
Insights zone 4 (I4)
Freya Vander Laenen
Thursday, 24 October
13:30
Short communication
Nurse-delivered injection education and subsequent injection drug use practices among street-involved youth
13:30
to
13:40
Networking zone 3 (N3)
Andreas Pilarinos
Oral presentation
HepCATT (Hepatitis C Assessment to Treatment Trial) in primary care: a cluster RCT of whether a complex intervention based on risk prediction algorithm tool and education can increase testing and diagnosis of HCV in primary care
13:30
to
13:45
Insights zone 1 (I1)
Matthew Hickman
13:40
Short communication
The impact of abused drugs spectrum among romanina IDU's on STI's, TB and blood born diseases in the last 10 years
13:40
to
13:50
Networking zone 3 (N3)
Adrian Abagiu
13:45
Oral presentation
Real-life effectiveness of direct-acting antiviral treatment among chronic hepatitis C infected opioid substituted patients in Germany
13:45
to
14:00
Insights zone 1 (I1)
Bernd Schulte
13:50
Short communication
Zero new infections of HIV among PWID, 4 consecutive years, a reality in Macau
13:50
to
14:00
Networking zone 3 (N3)
Augusto Nogueira
14:00
Short communication
Theory versus practice, bacteriological efficiency versus personal habits. A bacteriological and user acceptability evaluation of filtering tools for people who inject drugs.
14:00
to
14:10
Networking zone 3 (N3)
Marie Jauffret-Roustide
Oral presentation
Hepatitis C Virus (HCV) elimination and the opioid crisis: joint problems, joint solution – results of a pilot programme
14:00
to
14:15
Insights zone 1 (I1)
Brian Conway
14:10
Short communication
C+ |Be+| Be your rights... an example of community mobilisation in a neighborhood with an open scene of drug consumption in Porto.
14:10
to
14:20
Networking zone 3 (N3)
Rui Miguel Coimbra Morais
14:15
Oral presentation
Service Integration: accessing HCV treatment for homeless PWIDs/ex-PWIDs attending community OST
14:15
to
14:30
Insights zone 1 (I1)
Tina McHugh
14:20
Short communication
Innovative practices in harm reduction outreach teams in the city of Lisbon
14:20
to
14:30
Networking zone 3 (N3)
Inês Costa
Cristiana Merendeiro
14:30
Oral presentation
The cost-effectiveness of an HCV outreach intervention for at risk populations in London
14:30
to
14:45
Insights zone 1 (I1)
Zoe Ward
Oral presentation
Reduction in the population prevalence of chronic HCV among people who inject drugs associated with major scale-up of direct-acting antiviral therapy in community drug services: real world data
14:30
to
14:45
Insights zone 1 (I1)
Norah Palmateer
16:50
Oral presentation
Modeling economical costs of alcohol consumption in Germany: the GECO-ALC1 project
16:50
to
17:05
Central square 3 (C3)
Jakob Manthey
17:05
Oral presentation
Estimating substance use costs and harms in Canada
17:05
to
17:20
Central square 3 (C3)
Matthew Young
17:20
Oral presentation
Morbi-mortality consequences of misuse of psychoactive prescription drugs in Portugal: a retrospective observational study - the MisuMedPT project
17:20
to
17:35
Central square 3 (C3)
Ana Araújo
Friday, 25 October
10:55
Oral presentation
Evaluations of recreational cannabis legalisation in the US – overview and key lessons for policymakers
10:55
to
11:10
Networking zone 2 (N2)
Beau Kilmer
11:10
Oral presentation
Legalising cannabis for recreational purposes in Canada – practical challenges and opportunities for evaluating implementation and outcomes
11:10
to
11:25
Networking zone 2 (N2)
Rebecca Jesseman
11:25
Oral presentation
The role of evaluation in the development of the EU approach on drugs
11:25
to
11:40
Networking zone 2 (N2)
Danilo Ballotta
11:40
Oral presentation
Developing a flexible support package for EU Member States: EMCDDA’s ‘realistic’ policy evaluation approach
11:40
to
11:55
Networking zone 2 (N2)
Nicola Singleton